ESR1 and breast cancer: Sub-analysis indicated that FoxM1 mRNA high expression was correlated to shorter DMFS in BC patients with ER positive tumors (HR = 2.19, p < 0.0001) (Figure 4B), but not in ER negative tumors (HR = 0.98, p = 0.8623) (Figure 4C).